Scholarlink

Background <p>Chemotherapy-induced peripheral neuropathy (CIPN) and cancer-related fatigue (CRF) are prevalent and debilitating side effects in breast cancer patients, adversely affecting treatment adherence and quality of life. Although exercise is beneficial, a standardized, practical protocol for integrating nurse-led exercise interventions into clinical pathways during chemotherapy is not yet established.</p> Methods <p>A three-round modified Delphi study was conducted between February and May 2025 among a multidisciplinary panel of 22 experts, including oncology nurses, breast oncologists, rehabilitation therapists, and patient advocates. Anonymized, structured questionnaires were administered electronically. Consensus was predefined as a mean score ≥ 4.0 (on a 5-point Likert scale), agreement by ≥ 75% of respondents, and standard deviation ≤ 1.0. Kendall’s coefficient of concordance (W) was used to assess stability of rankings across rounds.</p> Results <p>High response rates were maintained across all rounds (100%, 95%, 100%). A strong consensus was achieved regarding 42 discrete items. Key agreements included: (1) initiating assessment and exercise prescription at the first chemotherapy cycle; (2) implementing a multi-component regimen combining aerobic, resistance, and balance training; (3) clearly defining nurses’ roles in assessment, education, and monitoring; (4) personalizing exercise intensity based on daily patient-reported symptoms (e.g., fatigue); and (5) integrating digital tools for adherence support and documentation.</p> Conclusions <p>This study establishes a robust expert consensus on a structured, nurse-led, personalized exercise intervention package for integration into the clinical pathway of breast cancer patients undergoing chemotherapy. The framework offers practical guidance for mitigating treatment-related side effects and improving patient outcomes. Future research should focus on evaluating its feasibility and effectiveness in diverse clinical settings.</p> Trial registration <p>Not applicable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A Delphi consensus for a nurse-led personalized exercise intervention in breast cancer patients during chemotherapy

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月19日

查看全文
  • Huijie Wei,
  • Wubin He

摘要

Background

Chemotherapy-induced peripheral neuropathy (CIPN) and cancer-related fatigue (CRF) are prevalent and debilitating side effects in breast cancer patients, adversely affecting treatment adherence and quality of life. Although exercise is beneficial, a standardized, practical protocol for integrating nurse-led exercise interventions into clinical pathways during chemotherapy is not yet established.

Methods

A three-round modified Delphi study was conducted between February and May 2025 among a multidisciplinary panel of 22 experts, including oncology nurses, breast oncologists, rehabilitation therapists, and patient advocates. Anonymized, structured questionnaires were administered electronically. Consensus was predefined as a mean score ≥ 4.0 (on a 5-point Likert scale), agreement by ≥ 75% of respondents, and standard deviation ≤ 1.0. Kendall’s coefficient of concordance (W) was used to assess stability of rankings across rounds.

Results

High response rates were maintained across all rounds (100%, 95%, 100%). A strong consensus was achieved regarding 42 discrete items. Key agreements included: (1) initiating assessment and exercise prescription at the first chemotherapy cycle; (2) implementing a multi-component regimen combining aerobic, resistance, and balance training; (3) clearly defining nurses’ roles in assessment, education, and monitoring; (4) personalizing exercise intensity based on daily patient-reported symptoms (e.g., fatigue); and (5) integrating digital tools for adherence support and documentation.

Conclusions

This study establishes a robust expert consensus on a structured, nurse-led, personalized exercise intervention package for integration into the clinical pathway of breast cancer patients undergoing chemotherapy. The framework offers practical guidance for mitigating treatment-related side effects and improving patient outcomes. Future research should focus on evaluating its feasibility and effectiveness in diverse clinical settings.

Trial registration

Not applicable.